1q23.3、2p23.3、2q33.3和2p21常见变异影响急性髓系白血病风险
Acute myeloid leukemia (AML) is a complex hematologic malignancy with multiple disease subgroups defined by somatic mutations and heterogeneous outcomes.…
要点
- 2p23.3 rs4665765与全AML风险显著相关(P=1.35×10-8),且与生存相关(P=6.09×10-3)。
- 1q23.3 rs12078864与伴5和/或7号染色体缺失的AML风险相关(P=7.0×10-10)。
- 2q33.3 rs12988876和2p21 rs79918355与细胞遗传学复杂AML风险相关。
核心结论
- 研究识别了全AML新的全基因组显著风险位点2p23.3,并发现多个疾病亚组特异性风险位点。
主要发现
- 2p23.3 rs4665765与全AML风险相关(P=1.35×10-8),涉及EFR3B、POMC、DNMT3A和DNAJC27,并与生存相关(P=6.09×10-3)。
- 1q23.3 rs12078864与伴5和/或7号染色体缺失的AML风险相关(P=7.0×10-10,DUSP23)。
- 2q33.3 rs12988876与细胞遗传学复杂AML风险相关(P=3.28×10-8,PARD3B)。
- 2p21 rs79918355与细胞遗传学复杂AML风险相关(P=1.60×10-9,EPCAM)。
- 多个与克隆性造血或未知潜能克隆性造血风险相关的位点变异与AML风险相关。
临床怎么用
- 这些风险位点有助于理解AML病因,并可能为风险分层提供遗传学信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute myeloid leukemia (AML) is a complex hematologic malignancy with multiple disease subgroups defined by somatic mutations and heterogeneous outcomes. Although genome-wide association studies (GWAS) have identified a small number of common genetic variants influencing AML risk, the heritable component of this disease outside of familial susceptibility remains largely undefined. Here, we perform a meta-analysis of 4 published GWAS plus 2 new GWAS, totaling 4710 AML cases and 12 938 controls. We identify a new genome-wide significant risk locus for pan-AML at 2p23.3 (rs4665765; P = 1.35 × 10-8; EFR3B, POMC, DNMT3A, and DNAJC27), which also significantly associates with patient survival (P = 6.09 × 10-3). Our analysis also identifies 3 new genome-wide significant risk loci for disease subgroups, including AML with deletions of chromosome 5 and/or 7 at 1q23.3 (rs12078864; P = 7.0 × 10-10; DUSP23) and cytogenetically complex AML at 2q33.3 (rs12988876; P = 3.28 × 10-8; PARD3B) and 2p21 (rs79918355; P = 1.60 × 10-9; EPCAM). We also investigated loci previously associated with the risk of clonal hematopoiesis (CH) or CH of indeterminate potential and identified several variants associated with the risk of AML. Our results further inform on AML etiology and demonstrate the existence of disease subgroup specific risk loci.
引用
- Ranasinghe D, Lin WY, Fordham SE, et al. Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia. Blood. 2026. PMID: 41610418. doi:10.1182/blood.2025031266
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。